Spiro Rombotis - Net Worth and Insider Trading
Spiro Rombotis Net Worth
The estimated net worth of Spiro Rombotis is at least $137,996 dollars as of 2024-04-30. Spiro Rombotis is the President and CEO of Cyclacel Pharmaceuticals Inc and owns about 68,658 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $137,996. Details can be seen in Spiro Rombotis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Spiro Rombotis has not made any transactions after 2023-12-21 and currently still holds the listed stock(s).
Transaction Summary of Spiro Rombotis
Spiro Rombotis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Spiro Rombotis owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of Spiro Rombotis’s form 4 insider trades.
Insider Ownership Summary of Spiro Rombotis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2023-12-21 | director & President & C.E.O. |
Spiro Rombotis Latest Holdings Summary
Spiro Rombotis currently owns a total of 1 stock. Spiro Rombotis owns 68,658 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of December 21, 2023, with a value of $137,996.
Latest Holdings of Spiro Rombotis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2023-12-21 | 68,658 | 2.01 | 137,996 |
Holding Weightings of Spiro Rombotis
Spiro Rombotis Form 4 Trading Tracker
According to the SEC Form 4 filings, Spiro Rombotis has made a total of 2 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cyclacel Pharmaceuticals Inc is the acquisition of 6,070 shares on December 21, 2023, which cost Spiro Rombotis around $20,152.
Insider Trading History of Spiro Rombotis
- 1
Spiro Rombotis Trading Performance
GuruFocus tracks the stock performance after each of Spiro Rombotis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Spiro Rombotis is -7.7%. GuruFocus also compares Spiro Rombotis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Spiro Rombotis within 3 months outperforms 5 times out of 15 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Spiro Rombotis's insider trading performs compared to the benchmark.
Performance of Spiro Rombotis
Average Return
19.88%
Outperforming Transactions
36%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.88 | -7.7 | 29.48 | 19.88 | -6.42 | -27.16 |
| Relative Return to S&P 500(%) | -11.52 | -6.72 | 25.35 | 5.78 | -14.54 | -31.07 |
Spiro Rombotis Ownership Network
Ownership Network List of Spiro Rombotis
Ownership Network Relation of Spiro Rombotis
Spiro Rombotis Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Spiro Rombotis is the director & President & C.E.O. of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & E.V.P. & Finance & C.O.O. Paul Mcbarron , Chief Medical Officer Mark Kirschbaum , and 10 percent owner Eastern Capital Ltd .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Spiro Rombotis made 1 insider transaction in Cyclacel Pharmaceuticals Inc (CYCC) with a net purchase of 6,070. Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 1,886 shares made by Paul Mcbarron ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Spiro Rombotis Mailing Address
Above is the net worth, insider trading, and ownership report for Spiro Rombotis. You might contact Spiro Rombotis via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
